Retinoic acid induces expression of the interleukin-1β gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines

Journal of Cellular Physiology

Volumn 193, Issue 2, 2002, Pages 244-252

  Liu, Limin ^a   Gudas, Lorraine J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA LIBRARY; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NORTHERN BLOTTING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST; BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; CYCLOHEXIMIDE; DACTINOMYCIN; DRUG SYNERGISM; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-1; KINETICS; MALE; PROSTATE; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, ESTROGEN; RECEPTORS, RETINOIC ACID; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED; UP-REGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0036836663     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10173     Document Type: Article

References (55)

1. Abdul M, Hoosein N. 2000. Differences in the expression and effects of interleukin-1 and -2 on androgen-sensitive and -insensitive human prostate cancer cell lines. Cancer Lett 149:37-42.
2. Alberts DS, Colvin OM, Conney AH, Ernster VL, Garber JE, Greenwald P, Gudas LJ, Hong WK, Kellof GJ, Kramer RA, Lerman CE, Mangelsdorf DJ, Matter A, Minna JD, Nelson WG, Pezzuto JM, Prendergast F, Rusch VW, Sporn MB, Wattenberg LW, Weinstein IB. 1999. Prevention of cancer in the next millenium: Report of the chemoprevention working group. Cancer Res 59:4743-4758.
3. Allenby G, Bocquel MT, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo JF, Chambon P. 1993. Retinoic acid receptors and retinoid X receptors: Interactions with endogenous retinoic acids. Proc Natl Acad Sci 90:30-34.
4. Alsayed Y, Uddin S, Mahmud N, Lekmine F, Kalvakolanu DV, Minucci S, Bokoch G, Platanias LC. 2001. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem 276:4012-4019.
5. Arend WP, Malyak M, Guthridge CJ, Gabay C. 1998. Interleukin-1 receptor antagonist: Role in biology. Ann Rev Immun 16:27-55.
6. Boylan JF, Lufkin T, Achkar CC, Taneja R, Chambon P, Gudas LJ. 1995. Targeted disruption of retinoic acid receptor α (RAR α) and RAR γ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol Cell Biol 15:843-851.
7. Chambon P. 1994. The retinoid signaling pathway: Molecular and genetic analyses. Semin Cell Biol 5:115-125.
8. Costantino A, Vinci C, Mineo R, Frasca F, Pandini G, Milazzo G, Vigneri R, Belfiore A. 1996. Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity. Endocrinology 137:4100-4107.
9. Danforth DN, Jr., Sgagias MK. 1991. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro. Cancer Res 51:1488-1493.
10. Danforth DN, Jr., Sgagias MK. 1993. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res 53:1538-1545.
11. Dinarello CA. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
12. Dinarello CA. 2000. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 343:732-734.
13. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC. 1990. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-346.
14. Eller MS, Yaar M, Ostrom K, Harkness DD, Gilchrest BA. 1995. A role for interleukin-1 in epidermal differentiation: Regulation by expression of functional versus decoy receptors. J Cell Sci 108:2741-2746.
15. Faria TN, LaRosa GJ, Wilen E, Liao J, Gudas LJ. 1998. Characterization of genes, which exhibit reduced expression during the retinoic acid-induced differentiation of F9 teratocarcinoma cells: Involvement of cychn D3 in RA-mediated growth arrest. Mol Cell Endocrinol 143:155-166.
16. Faria TN, Mendelsohn C, Chambon P, Gudas LJ. 1999. The targeted disruption of both alleles of RARβ2 in F9 cells results in the loss of retinoic acid-associated growth arrest. J Biol Chem 274:26783-26788.
17. Gidlof AC, Romert A, Olsson A, Törma H, Eriksson U, Sirsjo A. 2001. Increased retinoid signaling in vascular smooth muscle cells by proinflammatory cytokines. Biochem Biophys Res Comm 286:336-342.
18. Glass CK, Rosenfeld MG. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121-141.
19. Guo X, Ruiz A, Rando RR, Bok D, Gudas LJ. 2000. Esterification of all-trans-retinol in normal human epithelial cell strains and carcinoma lines from oral cavity, skin, and breast: Reduced expression of lecithin: retinol acyltransferase in carcinoma lines. Carcinogenesis 21:1925-1933.
20. Hashimoto S, Hayashi S, Yoshida S, Kujime K, Maruoka S, Matsumoto K, Gon Y, Koura T, Horie T. 1998. Retinoic acid differentially regulates interleukin-1beta and interleukin-1 receptor antagonist production by human alveolar macrophages. Leuk Res 22:1057-1061.
21. Hoffman AD, Engelstein D, Bogenrieder T, Papandreou CN, Steckelman E, Dave A, Motzer RJ, Dmitrovsky E, Albino AP, Nanus DM. 1996. Expression of retinoic acid receptor β in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid. Clin Cancer Res 2:1077-1082.
22. Hong WK, Sporn MB. 1997. Recent advances in chemoprevention of cancer. Science 278:1073-1077.
23. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ. 1991. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res 51:3972-3981.
24. Ichijo H. 1999. From receptors to stress-activated MAP kinases. Oncogene 18:6087-6093.
25. Jarrous N, Kaempfer R. 1994. Induction of human interleukin-1 gene expression by retinoic acid and its regulation at processing of precursor transcripts. J Biol Chem 269:23141-23149.
26. Jing Y, Zhang J, Bleiweiss IJ, Waxman S, Zelent A, Mira y Lopez R. 1996. Defective expression of cellular retinol binding protein type I and retinoic acid receptors α2, β2, and γ2 in human breast cancer cells. FASEB J 10:1064-1070.
27. Korzus E, Torchia J, Rose DW, Xu L, Kurokawa R, Mclnerney EM, Mullen TM, Glass CK, Rosenfeld MG. 1998. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279:703-707.
28. Langenfeld J, Kiyokawa H, Sekula D, Boyle J, Dmitrovsky E. 1997. Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism. Proc Natl Acad Sci 94:12070-12074.
29. Langston AW, Gudas LJ. 1992. Identification of a retinoic acid responsive enhancer 3′ of the murine homeobox gene Hox-1.6. Mech Dev 38:217-227.
30. Lee HY, Suh YA, Robinson MJ, Clifford JL, Hong WK, Woodgett JR, Cobb MH, Mangelsdorf DJ, Kurie JM. 2000. Stress pathway activation induces phosphorylation of retinoid X receptor. J Biol Chem 275:32193-32199.
31. Li Y, Glozak MA, Smith SM, Rogers MB. 1999. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: Modulation of growth by RXR-selective retinoids. Exp Cell Res 253:372-384.
32. Lotan R. 1996. Retinoids in cancer chemoprevention. FASEB J 10:1031-1039.
33. Love JM, Gudas LJ. 1994. Vitamin A, differentiation, and cancer. Curr Opin Cell Biol 6:825-831.
34. Matikainen S, Tapiovaara H, Vaheri A, Hurme M. 1994. Activation of interleukin-1 β gene expression during retinoic acid-induced granulocytic differentiation of promyeloid leukemia cells. Cell Growth Differ 5:975-982.
35. Matsuo T. 1998. p27Kip1: A key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line. Oncogene 16:3337-3343.
36. Miller WH, Jr. 1998. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 83:1471-1482.
37. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380.
38. Nikawa T, Ikemoto M, Tokuoka K, Teshima S, Alpers DH, Masui Y, Kishi K, Rokutan K. 2001. Interleukin-1β enhances retinoic acid-mediated expression of bone-type alkaline phosphatase in rat IEC-6 cells. Am J Physiol Gastroin Liver Physiol 280:510-517.
39. Niles RM. 2000. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. Nutrition 16:1084-1089.
40. Paciotti GF, Tamarkin L. 1988. Interleukin-1 directly regulates hormone-dependent human breast cancer cell proliferation in vitro. Mol Endocrinol 2:459-464.
41. Paciotti GF, Tamarkin L. 1991. Interleukin-1 α differentially synchronizes estrogen-dependent and estrogen-independent human breast cancer cells in the G0/G1 phase of the cell cycle. Anticancer Res 11:25-31.
42. Purohit A, de Giovani CV, Reed MJ. 1999. The regulation of oestrone sulphate formation in breast cancer cells. J Steroid Biochem Mol Biol 68:129-135.
43. Roman SD, Clarke CL, Hall RE, Alexander IE, Sutherland RL. 1992. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res 2236-2242.
44. Rosenauer A, Nervi C, Davison K, Lamph WW, Mader S, Miller WH, Jr. 1998. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression. Cancer Res 58:5110-5116.
45. Ross HJ. 1996. The antiproliferative effect of trans-retinoic acid is associated with selective induction of interleukin-1 β, a cytokine that directly inhibits growth of lung cancer cells. Oncol Res 8:171-178.
46. Schindler R, Clark BD, Dinarello CA. 1990. Dissociation between interleukin-1β mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem 265:10232-10237.
47. Seewaldt VL, Kim JH, Parker MB, Dietze EC, Srinivasan KV, Caldwell LE. 1999. Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro. Exp Cell Res 249:70-85.
48. Teixeira C, Pratt MA. 1997. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells. Mol Endocrinol 11:1191-1202.
49. Trechsel U, Evequoz V, Fleisch H. 1985. Stimulation of interleukin 1 and 3 production by retinoic acid in vitro. Biochem J 230:339-344.
50. Tsai SC, Gaffney EV. 1987. Modulation of cell proliferation by human recombinant interleukin-1 and immune interferon. J Natl Cancer Inst 79:77-81.
51. van der Burg B, van der Leede BM, Kwakkenbos-Isbrucker L, Salverda S, de Laat SW, van der Saag PT. 1993. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol 91:149-157.
52. Watkins LR, Hansen MK, Nguyen KT, Lee JE, Maier SF. 1999. Dynamic regulation of the proinflammatory cytokine, interleukin-lbeta: Molecular biology for non-molecular biologists. Life Sci 65:449-481.
53. White CM, Martin BK, Lee LF, Haskill JS, Ting JP. 1998. Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells. Cancer Immunol Immunother 46:104-112.
54. Xu L, Glass CK, Rosenfeld MG. 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 9:140-147.
55. Xu XC, Wong WY, Goldberg L, Baer SC, Wolf JE, Ramsdell WM, Alberts DS, Lippman SM, Lotan R. 2001. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res 61:4306-4310.